| Date Filed | Type | Description |
| 04/17/2019 |
4
| FRIEDLI PETER (Director) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Disposed/sold 10,204,404 shares
@ $19, valued at
$193.9M
Disposed/sold 4,103,301 shares
@ $19, valued at
$78M
Disposed/sold 500,000 shares
@ $19, valued at
$9.5M
Disposed/sold 2,750 shares
@ $19, valued at
$52.3k
|
|
| 07/25/2018 |
SC 13D/A
| FRIEDLI PETER reports a 42.9% stake in Osiris Therapeutics, Inc. |
| 02/07/2014 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $14.93, valued at
$149.3k
|
|
| 01/21/2014 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC. |
| 08/16/2013 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Paid exercise price by delivering 432,390 shares
@ $25.44, valued at
$11M
Exercised 1,000,000 warrants
@ $11, valued at
$11M
|
|
| 02/13/2013 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $7.73, valued at
$77.3k
|
|
| 12/28/2012 |
SC 13D/A
| FRIEDLI PETER reports a 44.9% stake in Osiris Therapeutics, Inc. |
| 12/10/2012 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Sold 50,000 shares
@ $9.52, valued at
$476k
|
|
| 11/16/2012 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Sold 625 shares
@ $9.34, valued at
$5.8k
|
|
| 03/27/2012 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $5.08, valued at
$50.8k
|
|
| 12/07/2011 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Gifted 500,000 shares
@ $4.87, valued at
$2.4M
|
|
| 02/16/2011 |
4
| FRIEDLI PETER (10% Owner) has filed a Form 4 on OSIRIS THERAPEUTICS, INC.|
Txns:
| Granted 10,000 shares
@ $7.13, valued at
$71.3k
|
|
| 02/25/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 09/25/2008 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 12/31/2007 |
SC 13D/A
| FRIEDLI PETER reports a 48.4% stake in Osiris Therapeutics, Inc. |
| 09/27/2007 |
SC 13D/A
| Form SC 13D/A -- General statement of acquisition of beneficial ownership [amend] |
| 06/13/2007 |
SC 13D/A
|
SEC Filing in the EDGAR database
|
| 12/20/2006 |
SC 13D
|
SEC Filing in the EDGAR database
|
| 11/02/2005 |
SC 13G/A
| FRIEDLI PETER reports a 0% stake in |
| 10/18/2005 |
SC 13G/A
| FRIEDLI PETER reports a 0% stake in |
| 09/27/2005 |
SC 13G/A
| FRIEDLI PETER reports a 0% stake in |
| 04/04/2005 |
SC 13D/A
| FRIEDLI PETER reports a 0% stake in |
| 04/07/2003 |
SC 13D/A
| FRIEDLI PETER reports a 0% stake in |
| 03/05/2003 |
SC 13G/A
| FRIEDLI PETER reports a 0% stake in |
| 02/06/2003 |
SC 13D
| FRIEDLI PETER reports a 0% stake in |
| 04/29/2002 |
SC 13G/A
| FRIEDLI PETER reports a 0% stake in |
| 02/14/2002 |
SC 13G/A
| FRIEDLI PETER reports a 0% stake in |
| 10/26/2001 |
SC 13G/A
| FRIEDLI PETER reports a 0% stake in |
| 05/21/2001 |
SC 13G
| FRIEDLI PETER reports a 0% stake in |
| 02/14/2001 |
SC 13G
| FRIEDLI PETER reports a 0% stake in |
| 02/08/2001 |
SC 13D
| FRIEDLI PETER reports a 0% stake in |
| 02/13/1997 |
SC 13D/A
| FRIEDLI PETER reports a 0% stake in |
| 11/08/1996 |
DEFC14A
| Form DEFC14A - Definitive proxy statement, contested solicitations: |
| 10/22/1996 |
SC 13D
| FRIEDLI PETER reports a 0% stake in |